Learn details of Glaucoma Pipeline therapeutics Review H1 2017. The report reviews pipeline therapeutics for Glaucoma by companies and universities/research institutes. The report reviews key players involved Glaucoma therapeutics includes AC Immune SA, Advanced Refractive Technologies Inc, Aerie Pharmaceuticals Inc, Allergan Plc, Altacor Ltd, Amarantus Bioscience Holdings Inc, Amgen Inc, Annexon Inc and more.
Glaucoma Pipeline Review H1 2017 provides an overview of Glaucoma (Ophthalmology) Pipeline landscape. Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The Glaucoma (Ophthalmology) pipeline guide reviews of key players involved in therapeutic development for Glaucoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 10, 22, 8, 56, 9 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 10 and 5 molecules, respectively.
Purchase This Glaucoma Pipeline Review H1 2017 Report of 280 Pages with Company profiles and Drugs Analysis athttp://www.reportsnreports.com/purchase.aspx?name=992874 .
Report provides comprehensive information on the therapeutics under development for Glaucoma (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Glaucoma (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Get Discount on This Report at: http://www.reportsnreports.com/contacts/discount.aspx?name=992874 .
The pipeline guide provides a snapshot of the global therapeutic landscape of Glaucoma (Ophthalmology) and reviews pipeline therapeutics for Glaucoma (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources. This report covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages also features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. key companies involved in Glaucoma (Ophthalmology) therapeutics and enlists all their major and minor projects also reviewed in Glaucoma (Ophthalmology) pipeline guide.
Glaucoma Pipeline by Companies Analyzed in report: AC Immune SA, Advanced Refractive Technologies Inc, Aerie Pharmaceuticals Inc, Allergan Plc, Altacor Ltd, Amarantus Bioscience Holdings Inc, Amgen Inc, Annexon Inc, Astellas Pharma Inc, Bausch & Lomb Inc, BioAxone BioSciences Inc, Bionure Farma SL, Can-Fite BioPharma Ltd, Clearside BioMedical Inc, D. Western Therapeutics Institute Inc, Dompe Farmaceutici SpA, Elsalys Biotech SAS, F. Hoffmann-La Roche Ltd, Gene Signal International SA, Gilead Sciences Inc, Glaukos Corp, Graybug Vision Inc, Han Wha Pharma Co Ltd, Handok Inc, Icon Bioscience Inc, ID Pharma Co Ltd, InMed Pharmaceuticals Inc, Inotek Pharmaceuticals Corp, Ironwood Pharmaceuticals Inc, Isarna Therapeutics GmbH, Kukje Pharmaceutical Industry Co Ltd, Laboratoires Thea SA, Laboratorios SALVAT SA, Laboratorios Sophia SA de CV, Lee’s Pharmaceutical Holdings Ltd, Lexicon Pharmaceuticals Inc, Merck & Co Inc, Mimetogen Pharmaceuticals Inc, Nemus Bioscience Inc, Neurim Pharmaceuticals Ltd, NicOx SA, NoNO Inc, Novaliq GmbH, Ocular Therapeutix Inc, Oculis ehf, Ohr Pharmaceutical Inc, Profarma, Q BioMed Inc, Quark Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co Ltd, Senju Pharmaceutical Co Ltd, Shire Plc, SK Biopharmaceuticals Co Ltd, Sun Pharma Advanced Research Company Ltd, Sun Pharmaceutical Industries Ltd, Sylentis SAU.
Table of Contents
Glaucoma – Overview
Glaucoma – Therapeutics Development
Glaucoma – Therapeutics Assessment
Glaucoma – Companies Involved in Therapeutics Development
Glaucoma – Drug Profiles
Glaucoma – Dormant Projects
Glaucoma – Discontinued Products
Glaucoma – Product Development Milestones
Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441